Veerakit Vanitshavit

Mr. Veerakit Vanitshavit

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Animals
Verified
Journal Article
Open access
PDF file
FOFrancis Joseph Oliaro
Francis Joseph Oliaro
OAOluwaseun David Ajileye
Oluwaseun David Ajileye
IGIris George
Iris George
KLKushal Raj Lamsal
Kushal Raj Lamsal
IMIlana Arielle Mosley
Ilana Arielle Mosley
LPLee Pinnell
Lee Pinnell
Closed recirculating aquatic systems (aquariums) offer a multitude of benefits including the ability to observe and research aquatic animals ex situ, and under controlled environmental conditions

17 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMANIVANNAN SUBRAMANIAN
MANIVANNAN SUBRAMANIAN
VVVeerakit Vanitshavit
Veerakit Vanitshavit
IGIris George
Iris George
LALeroy Arthur
Leroy Arthur
MAMustafa K. Abdelrahman
Mustafa K. Abdelrahman
TWTaylor Ware
Taylor Ware
Recurrent urinary tract infection (rUTI) is a significant public health problem. The most common cause of rUTI is uropathogenic Escherichia coli (UPEC). Antimicrobial prophylactic and therapeutic regimens for rUTI disrupts the microbiome and leads to infection with antimicrobial resistant organisms. Therefore, there is an urgent need to develop microbiome-sparing alternative approaches for preventing rUTI. Asymptomatic bacteriuria (ABU) E. coli strain 83972 (ABEC) outcompetes UPEC in the urinary tract without causing UTI symptoms, but its limited persistence in the bladder restricts its efficacy. Here, we investigate a device made from an engineered living material (ELM) that releases ABEC in a sustained manner as an antibiotic-free platform against UTIs and rUTIs. Using physiologically relevant in vitro models incorporating human urothelial cells, human urine, and periodic urine exchange, we show that ABEC-releasing ELMs suppress UPEC proliferation and inhibit UPEC attachment to and invasion into urothelial cells, particularly when ABEC is maintained at equal or higher levels than UPEC. Because ELMs continuously release ABEC, they sustain competitive pressure even as planktonic bacteria are cleared during voiding, outperforming a single dose of free-floating ABEC. In a rUTI model, sustained ABEC release from ELMs reduces the proliferation and reinvasion of UPEC expelled from infected urothelial cells, while UPEC infiltration into fractured ELMs remains negligible. Finally, we design a first-generation ELM device that can be transurethrally delivered and retained within the mouse urinary bladder, achieving sustained ABEC release in vivo, with ABEC persisting in the bladder, kidneys, and urine for at least 4 days. In summary, we report the development of an ELM device that continuously releases ABEC to suppress UPEC proliferation and urothelial cell invasion in in vitro models of rUTI, and demonstrate sustained ABEC release in vivo in a mouse bladder.